4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-053558
Chief Scientific Officer sold 6,000 shares at $5.08 ($30,460)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2023-10-23 | Sale 10b5-1 | −6,000 | $5.08 | $30,460 | 129,724 | D: show line 1 in the form |
| Open-market sales · 6,000 sh · avg $5.08 · $30,460 | |||||||
Loading xslF345X05/doc4.xml…